Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $294.3 million.

  • PROCEPT BioRobotics' Cash & Current Investments rose 4956.19% to $294.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $294.3 million, marking a year-over-year increase of 4956.19%. This contributed to the annual value of $333.7 million for FY2024, which is 2974.2% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its Cash & Current Investments stood at $294.3 million for Q3 2025, which was up 4956.19% from $302.7 million recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year Cash & Current Investments high stood at $333.7 million for Q4 2024, and its period low was $86.1 million during Q1 2021.
  • For the 5-year period, PROCEPT BioRobotics' Cash & Current Investments averaged around $245.1 million, with its median value being $257.2 million (2023).
  • Per our database at Business Quant, PROCEPT BioRobotics' Cash & Current Investments surged by 23011.45% in 2022 and then plummeted by 4423.1% in 2023.
  • PROCEPT BioRobotics' Cash & Current Investments (Quarter) stood at $304.3 million in 2021, then decreased by 26.84% to $222.6 million in 2022, then rose by 15.53% to $257.2 million in 2023, then rose by 29.74% to $333.7 million in 2024, then decreased by 11.82% to $294.3 million in 2025.
  • Its Cash & Current Investments was $294.3 million in Q3 2025, compared to $302.7 million in Q2 2025 and $316.2 million in Q1 2025.